Pfizer Subsidiary Recalls Mislabeled Drugs

Law360, New York (March 29, 2011, 5:15 PM EDT) -- A generic-drug maker subsidiary of Pfizer Inc. on Saturday announced the voluntary recall of a drug lot including Citalopram and Finasteride tablets because bottles were mislabeled.

The recall covers medicines with lot number FI0510058-A on the label, which includes bottles of Citalopram 10 mg tablets and Finasteride 5 mg tablets distributed in the U.S., Greenstone LLC said in a statement.

The company asked patients to return bottles of the drugs with that number to a pharmacist.

Greenstone said incorrect labels may have been placed on the...
To view the full article, register now.